Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement-Reference-Cited by-同舟云学术

Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement

Published:2023-08-17 Issue:12 Volume:64 Page:2002-2007
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Sastow Dahniel¹,Tatarian Joshua²,Riazat-Kesh Yosef J. R. A.³,Farina Kyle⁴,Becker Michelle¹,Feld Jonathan⁵,Kremyanskaya Marina⁵,Mascarenhas John⁵^ORCID,Byrd Kenneth²,Male Heather J.²,Lin Tara L.²,Tremblay Douglas⁵

Affiliation:

1. Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

2. University of Kansas Medical Center, Kansas City, KS, USA

3. Mount Sinai Morningside/West, New York, NY, USA

4. Department of Pharmacy Practice, The Mount Sinai Hospital, New York, NY, USA

5. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2248331

Reference14 articles.

1. Acute myeloid leukaemia

2. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome

3. Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia

4. CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials

5. Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report;Frontiers in Oncology;2024-07-02

2. Cytology or Multiparameter Flow Cytometry Positivity in the Cerebrospinal Fluid Before Transplantation is Predictive of Poor Outcomes After Allotransplantation in Acute Myeloid Leukemia Patients;Clinical Transplantation;2024-07

3. An abnormality in the cerebrospinal fluid before transplantation is predictive of poor outcomes after allotransplantation in AML patients;2024-03-19

4. Blast identification in cerebrospinal fluid specimens from patients with acute myeloid leukemia: laboratory perspectives;Leukemia & Lymphoma;2023-11-03